메뉴 건너뛰기




Volumn 22, Issue 14, 2014, Pages 3654-3669

Synthesis and evaluation of (E)-2-(acrylamido)cyclohex-1-enecarboxylic acid derivatives as HCA1, HCA2, and HCA3 receptor agonists

Author keywords

2 Acrylamidocyclohex 1 ene; Agonist; cAMP; Dyslipidemia; GPR109A; HCA2; Niacin

Indexed keywords

2 (ACRYLAMIDO)CYCLOHEX 1 ENECARBOXYLIC ACID DERIVATIVE; 2 AMIDOCYCLOHEX 1 ENE CARBOXYLIC ACID DERIVATIVE; 2 [3 (NAPHTHALEN 2 YL)PROPANAMIDO]CYCLOHEX 1 ENECARBOXYLIC ACID; 6 HYDROXYNAPHTHALEN 2 YL DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; CYCLIC AMP; ETHYL 2 [3 (2 CHLORO 3,4 DIMETHOXYPHENYL)ACRYLAMIDO]CYCLOHEX 1 ENECARBOXYLATE; ETHYL 2 [3 (2 CHLORO 6 METHOXYQUINOLIN 3 YL)ACRYLAMIDO]CYCLOHEX 1 ENECARBOXYLATE; ETHYL 2 [3 (2 CHLOROQUINOLIN 3 YL)ACRYLAMIDO]CYCLOHEX 1 ENECARBOXYLATE; ETHYL 2 [3 (2 METHYLQUINOLIN 6 YL)ACRYLAMIDO]CYCLOHEX 1 ENECARBOXYLATE; ETHYL 2 [3 (2,3 DIHYDROBENZO[B][1,4]DIOXIN 6 YL)ACRYLAMIDO]CYCLOHEX 1 ENECARBOXYLATE; ETHYL 2 [3 (3 BROMO 4,5 DIMETHOXYPHENYL)ACRYLAMIDO]CYCLOHEX 1 ENECARBOXYLATE; ETHYL 2 [3 (5,6,7 TRIMETHOXYQUINOLIN 2 YL)ACRYLAMIDO]CYCLOHEX 1 ENECARBOXYLATE; ETHYL 2 [3 (6 BROMOBENZO[D][1,3]DIOXOL 5 YL)ACRYLAMIDO]CYCLOHEX 1 ENECARBOXYLATE; ETHYL 2 [3 (6 CHLOROBENZO[D][1,3]DIOXOL 5 YL)ACRYLAMIDO]CYCLOHEX 1 ENECARBOXYLATE; ETHYL 2 [3 (6 METHOXYNAPHTHALEN 2 YL)ACRYLAMIDO]CYCLOHEX 1 ENECARBOXYLATE; ETHYL 2 [3 (NAPHTHALENE 2 YL)ACRYLAMIDE]CYCLOHEX 1 ENECARBOXYLATE; ETHYL 2 [3 (QUINOLIN 2 YL)ACRYLAMIDO]CYCLOHEX 1 ENECARBOXYLATE; ETHYL 2 [3 (QUINOLIN 4 YL)ACRYLAMIDO]CYCLOHEX 1 ENECARBOXYLATE; ETHYL 2 [3 (QUINOLIN 6 YL)ACRYLAMIDO]CYCLOHEX 1 ENECARBOXYLATE; ETHYL 2 [3 (QUINOLIN 8 YL)ACRYLAMIDO]CYCLOHEX 1 ENECARBOXYLATE; HYDROXYLCARBOXYLIC ACID RECEPTOR 1; HYDROXYLCARBOXYLIC ACID RECEPTOR 1 AGONIST; HYDROXYLCARBOXYLIC ACID RECEPTOR 2; HYDROXYLCARBOXYLIC ACID RECEPTOR 2 AGONIST; HYDROXYLCARBOXYLIC ACID RECEPTOR 3; HYDROXYLCARBOXYLIC ACID RECEPTOR 3 AGONIST; NICOTINIC ACID; RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; ACRYLAMIDE DERIVATIVE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; G PROTEIN COUPLED RECEPTOR; GPR81 PROTEIN, HUMAN; HCAR2 PROTEIN, HUMAN; HCAR3 PROTEIN, HUMAN; NICOTINIC RECEPTOR;

EID: 84902532493     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2014.05.011     Document Type: Article
Times cited : (10)

References (36)
  • 35
    • 0003688717 scopus 로고    scopus 로고
    • The trans stereochemistry of compound 19e and cis stereochemistry of compound 24 was confirmed by analysis of vicinal proton-proton coupling constants of the cyclopropyl moiety (J = 4.1 Hz for 19e and J = 9.2 Hz for 24). See, e.g., Springer-Verlag Berlin Heidelberg New York p 176
    • The trans stereochemistry of compound 19e and cis stereochemistry of compound 24 was confirmed by analysis of vicinal proton-proton coupling constants of the cyclopropyl moiety (J = 4.1 Hz for 19e and J = 9.2 Hz for 24). See, e.g. E. Pretsch, P. Bühlmann, and C. Affolter Structure Determination of Organic Compounds. Tables of Spectral Data. Third Completely Revised and Enlarged English Edition 2000 Springer-Verlag Berlin Heidelberg New York p 176
    • (2000) Structure Determination of Organic Compounds. Tables of Spectral Data. Third Completely Revised and Enlarged English Edition
    • Pretsch, E.1    Bühlmann, P.2    Affolter, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.